Yes, researchers are exploring the use of E. coli in targeted drug delivery systems. By engineering E. coli to express specific ligands or antibodies, these bacteria can be directed to target specific cells or tissues. E. coli can also be modified to release therapeutic agents in response to certain biological triggers, providing controlled and localized drug delivery. This approach has significant potential for improving the efficacy and reducing the side effects of various treatments, including cancer therapies.
